Fineline Cube

Follow:
14739 Articles
Sichuan Huiyu's CDCP1-Targeted ADC HY0001a Gets NMPA Clinical Trial Approval
CompanyDrug

Sichuan Huiyu’s CDCP1-Targeted ADC HY0001a Gets NMPA Clinical Trial Approval

Changshan Biochemical Receives NMPA Clearance for Albenatide in Weight Loss Trials
CompanyDrug

Changshan Biochemical Receives NMPA Clearance for Albenatide in Weight Loss Trials

ImmuneOnco Receives NMPA Approval for IMC-003/IMM72 in Pulmonary Arterial Hypertension Trial
CompanyDrug

ImmuneOnco Receives NMPA Approval for IMC-003/IMM72 in Pulmonary Arterial Hypertension Trial

United Imaging Intelligence Closes RMB 1B Series A Round to Boost AI in Healthcare
CompanyDeals

United Imaging Intelligence Closes RMB 1B Series A Round to Boost AI in Healthcare

MGI Tech's DNBSEQ-T1+ Gains CE IVDR Certification for EU Market Entry
CompanyMedical Device

MGI Tech’s DNBSEQ-T1+ Gains CE IVDR Certification for EU Market Entry

CompanyDeals

Jiangxi Rimag to Acquire 70% Stake in Guangzhou Gaomai for RMB 54 Million

Simcere Pharma's Quviviq Receives NMPA Approval for Insomnia Treatment
CompanyDrug

Simcere Pharma’s Quviviq Receives NMPA Approval for Insomnia Treatment

Sanofi and Regeneron Win FDA Approval for Dupixent in Bullous Pemphigoid Treatment
CompanyDrug

Sanofi and Regeneron Win FDA Approval for Dupixent in Bullous Pemphigoid Treatment

Zai Lab's Partner argenx Secures EU Approval for Vygart in CIDP Treatment
CompanyDrug

Zai Lab’s Partner argenx Secures EU Approval for Vygart in CIDP Treatment

Harbour BioMed and Otsuka Pharma Collaborate Globally on BCMAxCD3 Bispecific T-cell Engager
CompanyDeals

Harbour BioMed and Otsuka Pharma Collaborate Globally on BCMAxCD3 Bispecific T-cell Engager

CanSino Biologics' PCV13i Vaccine Gains NMPA Approval
CompanyDrug

CanSino Biologics’ PCV13i Vaccine Gains NMPA Approval

Zhongsheng Pharma's RAY1225 Enters Phase III Trial for Obesity/Overweight Treatment
CompanyDrug

Zhongsheng Pharma’s RAY1225 Enters Phase III Trial for Obesity/Overweight Treatment